Monthly Archives: March 2016

Hot Business News Today

Immunotec Announces Executive Promotions

by  •  • 0 Comments

 

Immunotec Inc., a direct- to-consumer company and a leader in the wellness industry (the “Company” or “Immunotec”), announced today three executive promotions.
Ms. Mimi Cohen has been promoted to the position of Vice-President, Marketing, Mr. David Marshall has been promoted to the position of Vice-President, Sales, Canada, the U.S., the UK and the Dominican Republic and Mr. David Pelletier has been promoted to the position of Vice- President, Regulatory Affairs, Quality Control & Product Development.
Mimi Cohen was Director, Marketing and Product Development and has been with the Company since the Fall of 2015. Ms. Cohen has been instrumental in the development and launch of Immunotec’s new Elasense™ Skin Care product line.
Prior to joining Immunotec, Ms. Cohen was Vice-President, Marketing and Visual Presentation at Reitmans Canada/Thyme Maternity. Ms. Cohen has extensive experience

Read more...

Hot Business News Today

Why Mannatech’s Clinical Trials Are Important To The Supplements Industry

by  •  • 0 Comments

 
By Al Bala, Mannatech Inc., CEO and President:
Mannatech is built on its pioneering glyconutritional technology, and I can’t think of any company in our industry that has the science and research that validates their products like we do.
We’ve said this many times before, but Mannatech’s technology has undergone 17 human clinical trials that have been published, 12 of which were double-blind, placebo-controlled studies — the gold standard for product validation.
But what does that mean, exactly? If you are a scientist working on any kind of technology that used by people internally, at some point you’ll want to have a human clinical trial. One of the most popular clinical trials is the double-blind, placebo-controlled trial that is recognized for minimizing bias in clinical testing.
Double-blind means that neither the subject of the study,

Read more...

Hot Business News Today

USANA Appoints D. Richard Williams To Board Of Directors

by  •  • 0 Comments

 
USANA Health Sciences, Inc. today announced the appointment of D. Richard Williams to the company’s board of directors effective March 1, 2016.
Mr. Williams joins the board as an independent director and brings a wealth of direct selling experience, as well as finance and corporate strategy expertise. The USANA board now has six members, five of whom are independent.
Myron W. Wentz, Ph.D., Chairman of the Board, commented, “Rick led Primerica as a Co-Chief Executive Officer for more than 15 years and continues to lead their company as Chairman of the Board.
He brings to our board more than twenty years of direct selling experience, along with expertise in a host of operating and financial areas that will provide significant value to USANA. I am delighted to have Rick join our board of

Read more...